AttendMe Owl Logo
AttendMe
Evidence Evolution
Emergency MedicineEmergency Medicine

How This Evidence Evolved

Sepsis Recognition and Early Treatment

From SIRS to Sepsis-3

1991-20236.3

Timeline

Trial
Guideline
Approval
Meta-analysis
Signal

Early observations and pilot data that first suggested a new direction

The 1991 ACCP/SCCM Consensus Conference established the Systemic Inflammatory Response Syndrome (SIRS) criteria as the basis for defining sepsis — any two of: temperature >38°C or <36°C, heart rate >90, respiratory rate >20, WBC >12,000 or <4,000. While groundbreaking for standardising sepsis definitions, SIRS proved overly sensitive and non-specific, capturing many non-infectious conditions.
Proof

Landmark RCTs and pivotal trials that established the evidence base

Rivers' EGDT trial (2001) demonstrated that protocolised early goal-directed therapy — targeting specific haemodynamic endpoints within 6 hours — reduced septic shock mortality from 46.5% to 30.5%. This single-centre trial transformed sepsis management. However, the multi-centre ProCESS (2014, N=1,341), ARISE (2014, N=1,600), and ProMISe (2015, N=1,260) trials subsequently showed that protocolised EGDT provided no benefit over usual care, effectively dismantling the specific protocol while preserving the principle of early aggressive treatment.
Extension

Follow-up studies, subgroup analyses, and real-world validation

The Sepsis-3 Task Force (Singer/Seymour 2016) redefined sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection, replacing SIRS criteria with the SOFA score. The qSOFA bedside screen (≥2 of: RR ≥22, altered mentation, SBP ≤100) was proposed for rapid identification outside the ICU. This reconceptualisation shifted focus from the inflammatory response to organ dysfunction.
Now

Current standard of care and ongoing research directions

Sepsis management emphasises early recognition, rapid antibiotics, and individualised resuscitation rather than protocolised targets. The Surviving Sepsis Campaign Hour-1 bundle recommends lactate measurement, blood cultures, broad-spectrum antibiotics, and fluid resuscitation within 1 hour. Debate continues over qSOFA's sensitivity in the ED versus the older SIRS criteria, and lactate-guided resuscitation remains under investigation.

Landmark Trials in This Story

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

What changed from SIRS to Sepsis-3?+
SIRS criteria (1991) defined sepsis based on inflammatory markers (temperature, heart rate, respiratory rate, WBC). Sepsis-3 (2016) redefined sepsis as life-threatening organ dysfunction, measured by the SOFA score, replacing the overly sensitive SIRS criteria with a focus on organ failure rather than inflammation.
What happened to early goal-directed therapy for sepsis?+
Rivers' EGDT trial (2001) showed mortality benefit from protocolised resuscitation. However, three large multi-centre trials (ProCESS, ARISE, ProMISe) found no benefit of EGDT over usual care. The principle of early, aggressive treatment was preserved but the specific protocol was abandoned.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Last reviewed: 30 March 2026